152 related articles for article (PubMed ID: 7908220)
1. Scintigraphic imaging of small-cell lung cancer with [111In]pentetreotide, a radiolabelled somatostatin analogue.
O'Byrne KJ; Ennis JT; Freyne PJ; Clancy LJ; Prichard JS; Carney DN
Br J Cancer; 1994 Apr; 69(4):762-6. PubMed ID: 7908220
[TBL] [Abstract][Full Text] [Related]
2. [Diagnostic value of somatostatin receptor scintigraphy with indium-111 pentetreotide in small-cell bronchial carcinoma].
Hoefer M; Schmidt S; Welter J; Kirsch CM; Ukena D; Sybrecht GW
Pneumologie; 1998 Feb; 52(2):106-12. PubMed ID: 9557059
[TBL] [Abstract][Full Text] [Related]
3. The use of radiolabeled somatostatin analog scintigraphy in the staging of small cell lung cancer patients.
Tzannou IA; Karapanagiotou EM; Charpidou A; Dilana K; Alamara C; Christakopoulou I; Georgiou E; Syrigos KN
Am J Clin Oncol; 2007 Oct; 30(5):503-6. PubMed ID: 17921711
[TBL] [Abstract][Full Text] [Related]
4. A metastatic neuroendocrine anaplastic small cell tumor in a patient with multiple endocrine neoplasia type 1 syndrome. Assessment of disease status and response to doxorubicin, cyclophosphamide, etoposide chemotherapy through scintigraphic imaging with 111In-pentetreotide.
O'Byrne KJ; Goggins MG; McDonald GS; Daly PA; Kelleher DP; Weir DG
Cancer; 1994 Oct; 74(8):2374-8. PubMed ID: 7922988
[TBL] [Abstract][Full Text] [Related]
5. Radiolabelled somatostatin analogue scintigraphy in oncology.
O'Byrne KJ; Carney DN
Anticancer Drugs; 1996 Jan; 7 Suppl 1():33-44. PubMed ID: 8822083
[TBL] [Abstract][Full Text] [Related]
6. Somatostatin receptor expression in lung cancer.
O'Byrne KJ; Halmos G; Pinski J; Groot K; Szepeshazi K; Schally AV; Carney DN
Eur J Cancer; 1994; 30A(11):1682-7. PubMed ID: 7833144
[TBL] [Abstract][Full Text] [Related]
7. Somatostatin-receptor scintigraphy in the management of gastroenteropancreatic tumors.
Krausz Y; Bar-Ziv J; de Jong RB; Ish-Shalom S; Chisin R; Shibley N; Glaser B
Am J Gastroenterol; 1998 Jan; 93(1):66-70. PubMed ID: 9448177
[TBL] [Abstract][Full Text] [Related]
8. Indium-111 pentetreotide in the diagnostic work-up of patients with bronchogenic carcinoma.
Kirsch CM; von Pawel J; Grau I; Tatsch K
Eur J Nucl Med; 1994 Dec; 21(12):1318-25. PubMed ID: 7875170
[TBL] [Abstract][Full Text] [Related]
9. Indium-111-pentetreotide scanning versus conventional imaging techniques for the localization of gastrinoma.
Schirmer WJ; Melvin WS; Rush RM; O'Dorisio TM; Pozderac RV; Olsen JO; Ellison EC
Surgery; 1995 Dec; 118(6):1105-13; discussion 1113-4. PubMed ID: 7491530
[TBL] [Abstract][Full Text] [Related]
10. In situ radiotherapy with 111In-pentetreotide: initial observations and future directions.
McCarthy KE; Woltering EA; Espenan GD; Cronin M; Maloney TJ; Anthony LB
Cancer J Sci Am; 1998; 4(2):94-102. PubMed ID: 9532411
[TBL] [Abstract][Full Text] [Related]
11. Somatostatin receptor imaging of small cell lung cancer (SCLC) by means of 111In-DTPA octreotide scintigraphy.
Bombardieri E; Crippa F; Cataldo I; Chiti A; Seregni E; Soresi E; Boffi R; Invernizzi G; Buraggi GL
Eur J Cancer; 1995; 31A(2):184-8. PubMed ID: 7718323
[TBL] [Abstract][Full Text] [Related]
12. Imaging of non-small-cell lung cancer with indium-111 pentetreotide.
Lau SK; Johnson DS; Coel MN
Clin Nucl Med; 2000 Jan; 25(1):24-8. PubMed ID: 10634526
[TBL] [Abstract][Full Text] [Related]
13. Somatostatin receptor imaging in small cell lung cancer.
Berenger N; Moretti JL; Boaziz C; Vigneron N; Morere JF; Breau JL
Eur J Cancer; 1996 Jul; 32A(8):1429-31. PubMed ID: 8869110
[TBL] [Abstract][Full Text] [Related]
14. 111In-octreotide scintigraphy in small cell lung cancer.
Semprebene A; Ferraironi A; Franciotti G; Venturo I; Giunta S; Lopez M; Maini CL
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):108-10. PubMed ID: 9002764
[TBL] [Abstract][Full Text] [Related]
15. Comparison of In-111 pentetreotide, Tc-99m (V)DMSA and I-123 mlBG scintimaging in neural crest tumors.
Limouris GS; Giannakopoulos V; Stavraka A; Toubanakis N; Vlahos L
Anticancer Res; 1997; 17(3B):1589-92. PubMed ID: 9179199
[TBL] [Abstract][Full Text] [Related]
16. Somatostatin and somatostatin analogues in medullary thyroid carcinoma.
O'Byrne KJ; O'Hare N; Sweeney E; Freyne PJ; Cullen MJ
Nucl Med Commun; 1996 Sep; 17(9):810-6. PubMed ID: 8895910
[TBL] [Abstract][Full Text] [Related]
17. Imaging of bronchial carcinoid tumours with indium-111 pentetreotide.
O'Byrne KJ; O'Hare NJ; Freyne PJ; Luke DA; Clancy LJ; Prichard JS; Carney DN
Thorax; 1994 Mar; 49(3):284-6. PubMed ID: 7911261
[TBL] [Abstract][Full Text] [Related]
18. Somatostatin receptor scintigraphy in the staging of small cell lung cancer.
Bohuslavizki KH; Brenner W; Günther M; Eberhardt JU; Jahn N; Tinnemeyer S; Wolf H; Sippel C; Clausen M; Gatzemeier U; Henze E
Nucl Med Commun; 1996 Mar; 17(3):191-6. PubMed ID: 8692484
[TBL] [Abstract][Full Text] [Related]
19. Imaging of somatostatin receptors by indium-111-pentetreotide correlates with quantitative determination of somatostatin receptor type 2 gene expression in neuroblastoma tumors.
Briganti V; Sestini R; Orlando C; Bernini G; La Cava G; Tamburini A; Raggi CC; Serio M; Maggi M
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2385-91. PubMed ID: 9815638
[TBL] [Abstract][Full Text] [Related]
20. 111In-Pentetreotide (OctreoScan) scintigraphy in the staging of small-cell lung cancer: its accuracy and prognostic significance.
Genestreti G; Bongiovanni A; Burgio MA; Burgio SL; Musto A; Rossi A; Monti M; Scarpi E; Ulivi P; Bravaccini S; Dubini A; Matteucci F; Gavelli G
Nucl Med Commun; 2015 Feb; 36(2):135-42. PubMed ID: 25321157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]